Mesenchymal stem cells for graft vs. host disease (Case Comprehensive Cancer Center)

This trial is studying the side effects and best dose of donor mesenchymal stem cells administered to treat patients who develop acute or chronic graft-versus-host disease after undergoing a donor stem cell transplantation.